J. Yarbro

发表

Oncogenes and cancer suppressor genes.

J. Yarbro, 1992, Seminars in oncology nursing.

Daunomycin inhibition of DNA and RNA synthesis

B. Kennedy, J. Yarbro, A. Theologides, 1968, Cancer.

American Joint Committee on Cancer prognostic factors consensus conference.

G. Murphy, D. Page, L. Fielding, 1999, Cancer.

Diagnosis and treatment of malignant pleural effusion

F. Hausheer, J. Yarbro, Frederick H Hausheer, 1985, Cancer and Metastasis Reviews.

Vascular toxicity associated with antineoplastic agents.

Q. S. Ringenberg, D. Doll, J. Yarbro, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

American Joint Committee on Cancer Prognostic Factors Consensus Conference

L. Fielding, E. Partridge, J. Yarbro, 1999, Cancer.

Antineoplastic agents and pregnancy.

Q. S. Ringenberg, D. Doll, J. Yarbro, 1989, Seminars in oncology.

Management of cancer during pregnancy.

Q. S. Ringenberg, D. Doll, J. Yarbro, 1988, Archives of internal medicine.

Immunotherapy of cancer with lymphokines and lymphokine-activated killer cells.

J. Yarbro, 1991, Seminars in surgical oncology.

Bleomycin increases superoxide production in the most active alveolar macrophage subpopulation.

J. Yarbro, R. Zeidler, N. S. Conley, 1987, International journal of immunopharmacology.

The need for Diagnosis-Related Group 471. Protection for clinical research.

L. Mortenson, J. Yarbro, 1985, JAMA.

Mycobacterial spinal cord abscess with an ascending polyneuropathy.

D. Doll, J. Yarbro, K. Phillips, 1987, Annals of internal medicine.

Effects of fractionated histones on nucleic acid synthesis in 6C3HED mouse ascites tumor cells and in normal spleen cells.

J. White, A. Levine, M. Nesbit, 1968, Cancer research.

Vascular toxicity associated with antineoplastic agents.

D. Doll, J. Yarbro, 1992, Seminars in oncology.

Chemotherapy of cervical carcinoma.

M. Perry, J. Yarbro, M. Muscato, 1982, Seminars in oncology.

Evans' syndrome associated with microcystic adenoma of the pancreas

A. List, D. Doll, J. Yarbro, 1987, Cancer.

Clinical trial with subcutaneously administered 5-azacytidine (NSC-102816).

P. Engstrom, M. Mastrangelo, R. Bellet, 1974, Cancer chemotherapy reports.

Further studies on the mechanism of action of hydroxyurea.

J. Yarbro, 1968, Cancer research.

Second cancers after radiotherapy for Hodgkin's disease.

C. N. Coleman, C. Coleman, M. Tucker, 1988, The New England journal of medicine.

Bleomycin increases superoxide anion generation by pig peripheral alveolar macrophages.

J. Yarbro, R. Zeidler, N. S. Conley, 1986, Molecular pharmacology.

Comparative effects of 1,10-phenanthroline and 1,7-phenanthroline on DNA and RNA synthesis in mouse spleen.

J. Yarbro, C. H. Chang, 1978, Life sciences.

Danazol therapy in acquired idiopathic sideroblastic anemia.

Q. S. Ringenberg, D. Doll, J. Yarbro, 1987, Acta haematologica.

Diagnosis and treatment of malignant pleural effusion.

F. Hausheer, J. Yarbro, 1985, Seminars in oncology.

Toxicity of chemotherapy

M. Perry, J. Yarbro, 1984 .

Malignant effusions as oncologic emergencies.

F. Hausheer, J. Yarbro, 1983, Progress in clinical and biological research.

An evaluation of the mechanism of action of pentamidine isethionate

J. Yarbro, R. Bornstein, 1970, Journal of surgical oncology.

Hydroxyurea. A new treatment for psoriasis.

J. Yarbro, U. Leavell, 1970, Archives of dermatology.

Mechanism of action of hydroxyurea.

J. Yarbro, 1992, Seminars in oncology.

Cytogenetic effects of bleomycin therapy in man.

D. Hungerford, P. Engstrom, J. Yarbro, 1971, Cancer research.

Immunotherapy: the need for critical studies.

R. Prehn, J. Yarbro, R. Bornstein, 1972, Annals of internal medicine.

Effect of hydroxyurea on regenerating rat liver.

W. Niehaus, J. Yarbro, C. Barnum, 1965, Biochemical and biophysical research communications.

Hydroxyurea inhibition of DNA synthesis in ascites tumor.

B. Kennedy, J. Yarbro, C. Barnum, 1965, Proceedings of the National Academy of Sciences of the United States of America.

Modified nucleosides in human serum.

K. Kuo, C. Gehrke, E. Mitchell, 1992, Journal of chromatography.

Chapter 6 High Performance Liquid Chromatography of Modified Nucleosides in Human Serum

K. Kuo, C. Gehrke, E. Mitchell, 1990 .

Metabolic and therapeutic effects of hydroxyurea in chronic myeloid leukemia.

B. Kennedy, J. Yarbro, 1966, JAMA.

Clinical and histologic correlation of melanoma regression after intralesional BCG therapy: a case report.

M. Mastrangelo, R. Prehn, J. Yarbro, 1974, Journal of the National Cancer Institute.

Relationship of histone synthesis to DNA synthesis in mouse ascites tumor 6C3HED.

J. Yarbro, 1967, Biochimica et biophysica acta.

ANTIMETABOLITE THERAPY OF PSORIASIS

J. Yarbro, U. Leavell, 1970, International journal of dermatology.

Hydroxyurea in the treatment of refractory psoriasis.

J. Yarbro, 1969, Lancet.

Future potential of adjuvant and neoadjuvant therapy.

J. Yarbro, 1991, Seminars in oncology.

A conceptual history of cancer.

C. Kardinal, J. Yarbro, 1979, Seminars in oncology.

Functional Hyposplenism

A. List, D. Doll, J. Yarbro, 1987, Southern medical journal.

Acanthocytosis associated with myelodysplasia.

Q. S. Ringenberg, A. List, T. Loy, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Corticosteroid Treatment of Hemolytic Anemia Associated With Mycoplasma pneumoniae Pneumonia

M. Hayden, S. Braun, J. Yarbro, 1990, Southern medical journal.

Ogata Phenomenon Explaining the Unusual Specificity in Eluates from Coombs Positive Cells Sensitized by Autogenous Anti‐I 1

J. Yarbro, E. Yunis, J. M. Svardal, 1967 .

Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999.

Daniel S. Miller, D. Bostwick, D. Grignon, 2000, Archives of pathology & laboratory medicine.

Mithramycin (NSC-24559) therapy for primary glioblastomas.

B. Kennedy, J. Yarbro, J. Brown, 1965, Cancer chemotherapy reports.

Hematologic Effects of Heavy Metal Poisoning

M. Perry, Q. S. Ringenberg, D. Doll, 1988, Southern medical journal.

Changing cancer care in the 1990s and the cost

J. Yarbro, 1991, Cancer.

Intralesional BCG in the treatment of metastatic malignant melanoma

M. Mastrangelo, R. Prehn, J. Yarbro, 1976, Cancer.

Immunotherapy of melanoma with intralesional BCG.

M. Mastrangelo, R. Prehn, J. Yarbro, 1973, National Cancer Institute monograph.

Further Studies on the Mechanism of Action of Hydroxyurea1

J. Yarbro, 2017 .

Effect of mithramycin on a mouse glioma.

B. Kennedy, J. Yarbro, M. Sandberg‐wollheim, 1968, Cancer research.

Effect of urethane, hydroxyurethane and hydroxyurea on synthesis of nucleic acid

B. Kennedy, J. Yarbro, Joseph Perpich, 1968, Cancer.

The effect of deoxyribonucleoside and ribonucleoside addition on the inhibitory effect of hydroxyurea on deoxyribonucleic acid synthesis.

J. Yarbro, 1967, The Biochemical journal.

Effect of methenolone enanthate (NSC‐64967) in advanced cancer of the breast

B. Kennedy, J. Yarbro, MD B. J. KENNEDY, 1968, Cancer.

Breast cancer examination experience of medical students and residents.

Q. S. Ringenberg, B. J. Kennedy, J. Yarbro, 1988, Journal of cancer education : the official journal of the American Association for Cancer Education.

Bone marrow involvement in small cell lung cancer. Clinical significance and correlation with routine laboratory variables

M. Perry, Q. S. Ringenberg, D. Doll, 1989, Cancer.

Effect of mithramycin on HeLa cells

B. Kennedy, J. Yarbro, M. Sandberg‐wollheim, 1968, Cancer.

Mithramycin inhibition of ribonucleic acid synthesis.

B. Kennedy, J. Yarbro, C. Barnum, 1966, Cancer research.

Malignant ascites of unknown origin

Q. S. Ringenberg, T. Loy, D. Doll, 1989, Cancer.

Hemolytic anemia associated with an ovarian tumor.

J. Yarbro, W. Talbert, M. Dawson, 1971, The American journal of medicine.

Acquired Pelger‐Huet anomaly in erythroleukemia

J. Yarbro, G. Konior, Bruce A. Phillips, 1970, Journal of Surgical Oncology.

National survey of the pattern of care for carcinoma of the lung.

D. Winchester, C. Smart, G. Steele, 1990, The Journal of thoracic and cardiovascular surgery.

Effects of 1,10-phenanthroline and a zinc complex of 1,10-phenanthroline on nucleic acid synthesis in mouse liver and spleen.

D. E. Mann, J. Yarbro, R. Gautieri, 1978, The Journal of pharmacology and experimental therapeutics.

Mechanism of action of vincristine sulfate. Abstr.

W. Krivit, M. Nesbit, J. Yarbro, 1968 .

Collecting cancer registry data with a Cancer Patient Questionnaire.

Q. S. Ringenberg, D. Doll, J. Yarbro, 1987, Journal of cancer education : the official journal of the American Association for Cancer Education.

Studies with tritiated mithramycin in C3H mice.

B. Kennedy, M. Loken, J. Yarbro, 1967, Cancer research.

Epidural spinal cord compression as the presenting manifestation of tumor of unknown origin.

Q. S. Ringenberg, D. Doll, J. Yarbro, 1990, Medical and pediatric oncology.

Tumors of unknown origin in the bone marrow.

M. Perry, Q. S. Ringenberg, D. Doll, 1986, Archives of internal medicine.

Vascular toxicity associated with chemotherapy and hormonotherapy.

D. Doll, J. Yarbro, 1994, Current opinion in oncology.

Minimal brain dysfunction and methylphenidate.

P. Engstrom, J. Yarbro, R. Bornstein, 1971 .

Choline antagonism of methotrexate liver toxicity in the rat.

J. Yarbro, S. Narrod, M. Freeman-Narrod, 1977, Medical and pediatric oncology.

Metabolic and therapeutic effects of hydroxyurea in chronic myelogenous leukemia.

B. Kennedy, J. Yarbro, 1965, Transactions of the Association of American Physicians.

Bone marrow biopsy in the initial staging of Hodgkin's disease.

D. Doll, J. Hewett, J. Yarbro, 1989, Medical and pediatric oncology.

Breast cancer: the new biology in conflict with the old dogma.

J. Yarbro, 1985, Seminars in oncology nursing.

Hydroxyurea: A New Treatment for Psoriasis

J. Yarbro, U. Leavell, 1970 .